Andrew’s Career in Healthcare spans 35 years. In his current role Andrew has responsibility for Healthcare Policy, supporting AWS public policy teams across the APAC region Previously Andrew led the Health Economics, Market Access, Policy and Government and Stakeholder Relations functions for Medtronic in Australia and New Zealand, in addition to coordinating Government Affairs for the APAC region. Before that Andrew had a variety of roles within Healthcare organisations across business and functional leadership. In addition to his Medtech experience, Andrew started his career as a Registered Nurse and has worked in the Pharmaceutical Industry as well as a brief stint in the Hospitality Industry. He holds an MBA from the University of New England and a BA in Media from Griffith University. He is an ARCS Australia Board Member and is Chair of the MTAA Digital Health Advisory Group and Co-Chair of the US-ASEAN Business Council Digital Health Committee.

Joanne is a Senior Manager at Commercial Eyes, leading the Access division of the Access, Research & Intelligence team. With a background in Biomedical Engineering and extensive consulting experience across Australia, Europe, and the UK, her expertise encompasses leading market assessment, access, reimbursement, and pricing submissions to the PBAC, MSAC, and MDHTAC. Before her tenure at Commercial Eyes, she was a Manager in the Health Economics and Outcomes Research team at Deloitte Belgium and worked in various segments of the English National Health Service (NHS), including renowned institutions like the National Institute for Health and Care Excellence (NICE). Specializing in strategy consulting, her skills include market access strategies, evidence-based assessments, health policy analysis, and stakeholder engagement. Her practical experience is augmented with hands-on involvement in the creation of product value dossiers, peer-reviewed manuscripts, and various strategic components essential for enhancing the value propositions of pharmaceutical agents and medical technologies.

Terry was Professor of Medicine at St Vincent's Hospital, Sydney from 1998-2017, and was Deputy Dean of Medicine at UNSW (2006-17). He is a clinical cardiologist who trained in Internal Medicine and Cardiology at St Vincent’s Hospital and in Pharmacology at Oxford University. His own research has encompassed both basic laboratory research in cardiac pharmacology and clinical cardiology, and he has published over 120 peer-reviewed papers in these fields. His work has been cited over 5000 times. He is a Past President of the Cardiac Society of Australia and New Zealand (2000-2), past Deputy Chair of the National Heart Foundation (NSW), and past Chair of the Therapeutics Advisory Committee of the Royal Australian College of Physicians (1996-2000). He served 15 years on the Pharmaceutical Benefits Advisory Committee (2001-16) and since 2016, has been Chair of the Medical Devices and Human Tissue Advisory Committee (previously PLAC), within the Australian Department of Health.